Retigabine (Trobalt) will be discontinued in June 2017

[EpilepsyAction1]

GlaxoSmithKline (GSK) is permanently discontinuing retigabine (Trobalt) from June 2017.

It will no longer be available after June.

GSK announced their plan to discontinue Trobalt last year.

If you take Trobalt your epilepsy specialist should have already discussed stopping this treatment, and possibly switching to another medicine instead.

If you have not already talked to your doctor about stopping Trobalt, it’s important to contact them as soon as possible. This is so you have time to safely stop taking it before stocks run out.

Diane

Epilepsy

Action Helpline Team

[avocadopeardrops]

Diane why is it being discontinued?

My neurologist told me yesterday that Clobazam may be barred in Canada due to cost.Thanks.

[EpilepsyAction1 Partner Epilepsy Action in reply to avocadopeardrops]

Hi Avocadopeardrops

Thank you for your question.

On this occasion GSK stopped this medicine for commercial reasons. Their reason was that only around 1,500 people worldwide were taking this medicine, and this number was getting smaller as doctors very rarely prescribed it.

Regards

Diane

Epilepsy Action Helpline Team